Angelman syndrome (AS) is a rare neuro‑developmental disorder that affects one in 15,000 people. Our mission is to advance the awareness and treatment of AS with the ultimate goal of finding a cure.
If you’re overwhelmed by a new diagnosis, you’ve come to the right place.
Adulthood brings new rewards and challenges. Find resources here.
Find resources and programs to make your journey easier and more informed.
Explore ways you can contribute to the ASF mission & connect with others in the Angelman community.
The Angelman Syndrome Foundation (ASF) is committed to supporting families when and where they need it most.
Angelman syndrome is a rare neuro‑developmental disorder that affects one in 15,000 people or 500,000 people worldwide.
Angelman syndrome shares symptoms and characteristics with other disorders including autism, cerebral palsy and Prader-Willi syndrome. Due to the common characteristics, misdiagnosis occurs often.
ASF’s pilot funding gives researchers the early support they need to prove a concept and generate critical preliminary data. This proof is required to receive major grants from the NIH and other funding organizations.
This strategic early investment has already helped unlock more than $200 million in funding, allowing promising ideas to grow into fully funded research programs. This strategy creates momentum and turns small investments into transformative impact.
Angelman syndrome research studies are happening at universities and medical centers all over the world. Participation is one way you can help advance research and understanding of Angelman syndrome. Studies are conducted in person and virtually, through surveys and interviews, or tests and medical procedures. Explore current studies and determine if participation is right for your family.
Our research funding strategy is guided by four key pillars, each targeting a critical area of Angelman syndrome science and care.
